A detailed history of Nemes Rush Group LLC transactions in Mimedx Group, Inc. stock. As of the latest transaction made, Nemes Rush Group LLC holds 8,380 shares of MDXG stock, worth $73,744. This represents 0.01% of its overall portfolio holdings.

Number of Shares
8,380
Previous 16,224 48.35%
Holding current value
$73,744
Previous $112 Million 42.61%
% of portfolio
0.01%
Previous 0.02%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$5.65 - $7.76 $44,318 - $60,869
-7,844 Reduced 48.35%
8,380 $64.5 Million
Q2 2024

Aug 15, 2024

BUY
$6.16 - $8.08 $48,319 - $63,379
7,844 Added 93.6%
16,224 $112 Million
Q4 2023

Feb 09, 2024

SELL
$5.7 - $9.14 $39,449 - $63,257
-6,921 Reduced 45.23%
8,380 $73.5 Million
Q2 2023

Aug 02, 2023

BUY
$3.14 - $6.61 $48,045 - $101,139
15,301 New
15,301 $101 Million

Others Institutions Holding MDXG

About MIMEDX GROUP, INC.


  • Ticker MDXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 113,609,000
  • Market Cap $1B
  • Description
  • MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins. The company's patented and proprietary pr...
More about MDXG
Track This Portfolio

Track Nemes Rush Group LLC Portfolio

Follow Nemes Rush Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nemes Rush Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nemes Rush Group LLC with notifications on news.